Sentieon

About:

Enable Precision Data for Precision Medicine

Website: http://www.sentieon.com/

Twitter/X: sentieon

Top Investors: Mission BioCapital, Amino Capital, Centana Growth Partners, Boehringer Ingelheim Venture Fund, Ten Coves Capital

Description:

Sentieon develops and commercializes cloud-based bio-informatics solutions for the life sciences and clinical market. They develop and supply a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, accuracy, and consistency. Some of the released products include Sentieon DNAseq, a germline DNA pipeline; and Sentieon TNseq, for tumor-normal somatic variant detection. The company’s tools are scalable, deployable, upgradable, and software-only solutions. The Sentieon tools achieve their efficiency and consistency through optimized computing algorithm design and enterprise-strength software implementation. The company was founded by Jun Ye in 2014 and is headquartered in Mountain View, California.